Cargando…

Comparison of treatment outcome definitions in drug-resistant tuberculosis patients with high incidence of acquired second-line drug resistance

BACKGROUND: Simplified drug-resistant tuberculosis (DR-TB) treatment outcome definitions, mostly centred around receipt of treatment and sputum culture status at 6 months after treatment initiation, have been proposed, but have not been widely evaluated in resource-limited settings. OBJECTIVES: To c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Anderson, K, Pietersen, E, Dheda, K, van der Heijden, Y F
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	South African Medical Association 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9379990/ https://www.ncbi.nlm.nih.gov/pubmed/35991341 http://dx.doi.org/10.7196/AJTCCM.2022.v28i2.177

Ejemplares similares

High mortality among patients hospitalized for drug‐resistant tuberculosis with acquired second‐line drug resistance and high HIV prevalence
por: Anderson, Kim, et al.
Publicado: (2022)

Variation in missed doses and reasons for discontinuation of anti-tuberculosis drugs during hospital treatment for drug-resistant tuberculosis in South Africa
por: Pietersen, Elize, et al.
Publicado: (2023)

GenoType(®) MTBDRsl assay for resistance to second‐line anti‐tuberculosis drugs
por: Theron, Grant, et al.
Publicado: (2016)

Incidence and predictors of acquired resistance to second-line antituberculosis drugs during the course of multi-drug resistant tuberculosis treatment: protocol for a systematic review and meta-analysis
por: Alemu, Ayinalem, et al.
Publicado: (2023)

The diagnostic accuracy of the GenoType® Mtbdrsl assay for the detection of resistance to second-line anti-tuberculosis drugs
por: Theron, Grant, et al.
Publicado: (2014)

Drug Resistance Patterns of Multidrug- and Extensively Drug-Resistant Tuberculosis in Korea: Amplification of Resistance to Oral Second-line Drugs
por: Kim, Chang-Ki, et al.
Publicado: (2017)

Detection of Second Line Drug Resistance among Drug Resistant Mycobacterium Tuberculosis Isolates in Botswana
por: Mogashoa, Tuelo, et al.
Publicado: (2019)

Second-line anti-tuberculosis drug resistance testing in Ghana identifies the first extensively drug-resistant tuberculosis case
por: Osei-Wusu, Stephen, et al.
Publicado: (2018)

What is new in the WHO consolidated guidelines on drug-resistant tuberculosis treatment?
por: Sharma, Surendra K., et al.
Publicado: (2019)

Detection of second-line drug resistance in Mycobacterium tuberculosis using oligonucleotide microarrays
por: Zimenkov, Danila V, et al.
Publicado: (2013)

First and Second-Line Anti-Tuberculosis Drug-Resistance Patterns in Pulmonary Tuberculosis Patients in Zambia
por: Monde, Ngula, et al.
Publicado: (2023)

Prevalence of resistance to second-line tuberculosis drug among multidrug-resistant tuberculosis patients in Viet Nam, 2011
por: Nguyen, Hoa Binh, et al.
Publicado: (2016)

High Frequency of Resistance, Lack of Clinical Benefit, and Poor Outcomes in Capreomycin Treated South African Patients with Extensively Drug-Resistant Tuberculosis
por: Pietersen, Elize, et al.
Publicado: (2015)

Resistance to Second-Line Antituberculosis Drugs and Delay in Drug Susceptibility Testing among Multidrug-Resistant Tuberculosis Patients in Shanghai
por: Chen, Yong, et al.
Publicado: (2016)

Genetic Characterization of Second-Line Drug-Resistant and Extensively Drug-Resistant Mycobacterium tuberculosis from the Northern Region of India
por: Yadav, Rakesh, et al.
Publicado: (2018)

Second-line Drug Resistance Characterization in Mycobacterium tuberculosis by Genotype MTBDRsl Assay
por: Sethi, Sunil, et al.
Publicado: (2020)

Effects of second-line anti-tuberculosis drugs on the intestinal microbiota of patients with rifampicin-resistant tuberculosis
por: Wu, Chunli, et al.
Publicado: (2023)

Characterization of Genetic Mutations in Multi-Drug-Resistant Isolates of Mycobacterium tuberculosis Bacilli Conferring Resistance to a Second-Line Anti-tuberculosis Drug
por: Sharma, Raj Kishor, et al.
Publicado: (2023)

Prevalence and Molecular Characterization of Second-Line Drugs Resistance among Multidrug-Resistant Mycobacterium tuberculosis Isolates in Southwest of China
por: Hu, Y., et al.
Publicado: (2017)

Increasing prevalence of resistance to second-line drugs among multidrug-resistant Mycobacterium tuberculosis isolates in Kuwait
por: Al-Mutairi, Noura M., et al.
Publicado: (2021)

Consensus Statement on Research Definitions for Drug-Resistant Tuberculosis in Children
por: Seddon, James A., et al.
Publicado: (2013)

The Reductionist Conundrum of an “Updated” Definition of Extensively Drug-Resistant Tuberculosis
por: Mitnick, Carole D., et al.
Publicado: (2021)

Genomic Analysis of Mycobacterium tuberculosis Strains Resistant to Second-Line Anti-Tuberculosis Drugs in Lusaka, Zambia
por: Chizimu, Joseph Yamweka, et al.
Publicado: (2023)

Mutation and Transmission Profiles of Second-Line Drug Resistance in Clinical Isolates of Drug-Resistant Mycobacterium tuberculosis From Hebei Province, China
por: Li, Qianlin, et al.
Publicado: (2019)

Application of quantitative second-line drug susceptibility testing at a multidrug-resistant tuberculosis hospital in Tanzania
por: Mpagama, Stellah G, et al.
Publicado: (2013)

What is the Cost of Diagnosis and Management of Drug Resistant Tuberculosis in South Africa?
por: Pooran, Anil, et al.
Publicado: (2013)

Acquired Drug Resistance in Mycobacterium tuberculosis and Poor Outcomes among Patients with Multidrug-Resistant Tuberculosis
por: Kempker, Russell R., et al.
Publicado: (2015)

Initial second-line drug resistance of Mycobacterium tuberculosis isolates from Sudanese retreatment-patients
por: Adam, Muatsim Ahmed Mohammed, et al.
Publicado: (2017)

Molecular characterisation of second-line drug resistance among drug resistant tuberculosis patients tested in Uganda: a two and a half-year’s review
por: Mujuni, Dennis, et al.
Publicado: (2022)

Acquired bedaquiline resistance during the treatment of drug-resistant tuberculosis: a systematic review
por: Mallick, Jahan Saeed, et al.
Publicado: (2022)

Molecular characterisation of mutations associated with resistance to first- and second-line drugs among Indonesian patients with tuberculosis
por: Umar, Faiqah F., et al.
Publicado: (2020)

Molecular characterization of mutations associated with resistance to second-line tuberculosis drug among multidrug-resistant tuberculosis patients from high prevalence tuberculosis city in Morocco
por: Oudghiri, Amal, et al.
Publicado: (2018)

The Incidence of Drug Resistant Tuberculosis in 1279 Korean Patients
por: Yum, Hokee, et al.
Publicado: (1995)

The diagnostic accuracy of the MTBDRplus and MTBDRsl assays for drug-resistant TB detection when performed on sputum and culture isolates
por: Tomasicchio, Michele, et al.
Publicado: (2016)

Drug-resistant tuberculosis in subjects included in the Second National Survey on Antituberculosis Drug Resistance in Porto Alegre, Brazil,
por: Micheletti, Vania Celina Dezoti, et al.
Publicado: (2014)

Transmission, distribution and drug resistance-conferring mutations of extensively drug-resistant tuberculosis in the Western Cape Province, South Africa
por: Oostvogels, Selien, et al.
Publicado: (2022)

Acquired Resistance to Antituberculosis Drugs
por: Aung, Htin Lin, et al.
Publicado: (2018)

Drug-adapted cancer cell lines as preclinical models of acquired resistance
por: Michaelis, Martin, et al.
Publicado: (2019)

Low Resistance to First and Second Line Anti-Tuberculosis Drugs among Treatment Naive Pulmonary Tuberculosis Patients in Southwestern Uganda
por: Orikiriza, Patrick, et al.
Publicado: (2015)

Molecular characterization of mutations associated with resistance to second line drugs in Mycobacterium tuberculosis patients from Casablanca, Morocco
por: Momen, Ghizlane, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_4io1bm54n292fv91it98stulbn